PepsiCo, Inc. vs Pfizer Inc.: Strategic Comparison
Key Differences at a Glance
| Field | PepsiCo, Inc. | Pfizer Inc. |
|---|---|---|
| Revenue | $93.9B | $62.6B |
| Founded | 1965 | 1849 |
| Employees | 306,000 | 75,000 |
| Market Cap | $205.0B | $148.0B |
| Headquarters | United States | United States |
Quick Stats Comparison
| Metric | PepsiCo, Inc. | Pfizer Inc. |
|---|---|---|
| Revenue | $93.9B | $62.6B |
| Founded | 1965 | 1849 |
| Headquarters | Purchase, New York | New York, New York |
| Market Cap | $205.0B | $148.0B |
| Employees | 306,000 | 75,000 |
PepsiCo, Inc. Revenue vs Pfizer Inc. Revenue — Year by Year
| Year | PepsiCo, Inc. | Pfizer Inc. | Leader |
|---|---|---|---|
| 2025 | $93.9B | $62.6B | PepsiCo, Inc. |
| 2024 | $91.9B | $63.6B | PepsiCo, Inc. |
| 2023 | $91.5B | $59.6B | PepsiCo, Inc. |
| 2022 | $86.4B | $101.2B | Pfizer Inc. |
| 2021 | $79.5B | $81.3B | Pfizer Inc. |
Business Model Breakdown
Overview: PepsiCo, Inc. vs Pfizer Inc.
This in-depth comparison examines PepsiCo, Inc. and Pfizer Inc. across revenue, market value, business model, competitive positioning, and long-term growth strategy. Whether you are researching PepsiCo, Inc. on its own, evaluating Pfizer Inc., or weighing the two companies side by side, the breakdown below highlights where each company leads and where the gap between PepsiCo, Inc. and Pfizer Inc. is widest.
On the headline numbers, PepsiCo, Inc. reports annual revenue of $93.9B against $62.6B for Pfizer Inc., while their respective market capitalizations stand at $205.0B and $148.0B. PepsiCo, Inc. is headquartered in United States and Pfizer Inc. operates from United States, and those different home markets shape how each company competes.
PepsiCo, Inc.: PepsiCo is often framed through the cola wars, but the Frito-Lay system is the real structural engine. The 1965 merger created a company that could negotiate with retailers using both snacks and beverages, turning distribution breadth into an economic moat.
Pfizer Inc.: Pfizer has repeatedly reinvented itself around new therapeutic waves, from industrial fermentation and penicillin to Lipitor, vaccines, COVID products, and now oncology. The 2025 profile is not a pandemic windfall story; it is a large pharmaceutical company trying to rebuild a durable growth base.
Business Models: How PepsiCo, Inc. and Pfizer Inc. Make Money
PepsiCo, Inc. and Pfizer Inc. pursue distinct approaches to generating revenue, and understanding how each company operates is the foundation of any fair comparison between PepsiCo, Inc. and Pfizer Inc..
PepsiCo, Inc. business model: PepsiCo makes money from convenient foods, beverages, concentrates, foodservice, licensing, and international packaged-food operations. The company sells finished products through company-owned and third-party distribution, and it benefits from direct-store-delivery strength in snacks and beverages.
Pfizer Inc. business model: Pfizer makes money from patented prescription medicines, vaccines, oncology products, hospital therapies, rare disease products, collaborations, and global commercial distribution. Its economics depend on R&D success, regulatory approvals, patent protection, reimbursement, and lifecycle management.
Competitive Advantage: PepsiCo, Inc. vs Pfizer Inc.
The durability of a company's moat often decides long-term winners. Here is how the competitive advantages of PepsiCo, Inc. stack up against those of Pfizer Inc..
PepsiCo, Inc. competitive advantage: PepsiCo advantage comes from the combination of Frito-Lay scale, beverage brands, global distribution, direct-store delivery, product breadth, retailer relationships, and marketing investment.
Pfizer Inc. competitive advantage: Pfizer advantage is scale: global regulatory expertise, manufacturing capacity, clinical development experience, commercial infrastructure, vaccine capabilities, and the ability to acquire or partner for scientific platforms.
Growth Strategy: Where PepsiCo, Inc. and Pfizer Inc. Are Headed
Future prospects matter as much as current results. The growth strategies below explain how PepsiCo, Inc. and Pfizer Inc. each plan to expand from here.
PepsiCo, Inc. growth strategy: PepsiCo strategy centers on international growth, productivity, brand restages, zero-sugar beverages, functional hydration, convenient foods, and portfolio renovation. Steve Schmitt became CFO effective November 10, 2025, adding new finance leadership for the next phase of cost discipline.
Pfizer Inc. growth strategy: Pfizer growth strategy emphasizes oncology, vaccines, internal medicine, obesity and metabolic research, business development discipline, cost reduction, and global commercial execution. Chris Boshoff became Chief Scientific Officer and President, Research & Development effective January 1, 2025.
Financial Picture: PepsiCo, Inc. vs Pfizer Inc.
A closer look at the financial trajectory of PepsiCo, Inc. and Pfizer Inc. rounds out the comparison.
PepsiCo, Inc.: PepsiCo reported $93.925 billion of FY2025 net revenue, up from $91.854 billion in FY2024 and $91.471 billion in FY2023. FY2025 net income attributable to PepsiCo was $8.240 billion. PepsiCo employed approximately 306,000 people worldwide as of December 27, 2025.
Pfizer Inc.: Pfizer reported $62.579 billion of FY2025 revenue, compared with $63.627 billion in FY2024 and $59.553 billion in FY2023. Net income was $7.771 billion in FY2025. Pfizer employed approximately 75,000 people worldwide as of December 31, 2025.
Company-Specific SWOT Notes
PepsiCo, Inc.
PepsiCo combines Frito-Lay snack leadership, beverage brands, retailer relationships, and global distribution.
Pricing-led growth can pressure volumes, while sugar, sodium, and processed-food scrutiny challenge legacy categories.
Zero-sugar beverages, hydration, permissible indulgence, international foods, and premium snack brands can refresh the portfolio.
Retailers can push private labels and demand price concessions, especially when consumers are under affordability pressure.
Pfizer Inc.
Pfizer has manufacturing, regulatory, clinical, and commercial infrastructure that few competitors can match globally.
Major products face loss of exclusivity and pricing pressure, requiring strong replacement revenue.
The Seagen acquisition gives Pfizer a larger oncology platform and ADC pipeline if clinical and commercial execution succeeds.
Medicare negotiation, generic competition, and failed pipeline readouts can compress revenue and margins.
Head-to-Head Scorecard
| Category | Winner | Why |
|---|---|---|
| Revenue Scale | PepsiCo, Inc. | PepsiCo, Inc. reports the larger revenue base ($93.9B), which serves as a core operational scale signal. |
| Profitability Potential | Comparable | Both organizations prioritize market penetration or are at equivalent reporting tiers. |
| Company Age | Pfizer Inc. | Founded in 1965 vs 1849. The earlier pioneer typically commands longer historical institutional legacy. |
| Innovation Moat | PepsiCo, Inc. | Higher aggregate count of major acquisitions and key R&D releases indicates a more active technology absorption velocity. |
| Scale (Employees) | PepsiCo, Inc. | A significantly larger reported workforce supports enhanced global distribution capability. |
| Market Cap | PepsiCo, Inc. | Higher public valuation denotes greater forward-looking investor conviction in earnings potential. |
| Future Outlook | Tied | Strategic auditing assesses that both maintain defensive leadership vectors within their core market clusters. |
Who Wins Each Category?
PepsiCo, Inc. reports the larger revenue base ($93.9B), which serves as a core operational scale signal.
Both organizations prioritize market penetration or are at equivalent reporting tiers.
Founded in 1965 vs 1849. The earlier pioneer typically commands longer historical institutional legacy.
Higher aggregate count of major acquisitions and key R&D releases indicates a more active technology absorption velocity.
A significantly larger reported workforce supports enhanced global distribution capability.
Who Wins: PepsiCo, Inc. or Pfizer Inc.?
Reviewed by Swet Parvadiya, May 2026 - Author Profile
Our analysts compile business strategy profiles from public financial filings, press releases, and analyst reports. Each profile is reviewed for accuracy before publication by our editorial desk and updated on a rolling basis.
Frequently Asked Questions: PepsiCo, Inc. vs Pfizer Inc.
Is PepsiCo, Inc. better than Pfizer Inc.?
Verdict: Between PepsiCo, Inc. and Pfizer Inc., PepsiCo, Inc. is the stronger overall option based on higher annual revenue. The decision still depends on which factors matter most for your needs, but on the weight of the evidence above, PepsiCo, Inc. comes out ahead in this PepsiCo, Inc. vs Pfizer Inc. comparison.
Who earns more — PepsiCo, Inc. or Pfizer Inc.?
PepsiCo, Inc. earns more with $93.9B in annual revenue versus Pfizer Inc.'s $62.6B. PepsiCo, Inc. leads on total revenue based on latest verified figures.
Which company has higher revenue — PepsiCo, Inc. or Pfizer Inc.?
PepsiCo, Inc. reported $93.9B, while Pfizer Inc. reported $62.6B. The revenue leader is PepsiCo, Inc. based on latest verified figures.
PepsiCo, Inc. revenue vs Pfizer Inc. revenue — which is higher?
PepsiCo, Inc. revenue: $93.9B. Pfizer Inc. revenue: $62.6B. PepsiCo, Inc. has the larger revenue base of the two companies.
Sources & References
- SEC EDGAR: PepsiCo, Inc. Annual Filings (10-K, 8-K)
- PepsiCo, Inc. Corporate Website
- PepsiCo, Inc. Annual Report 2025 - Revenue and Financial Data
- sec.gov
- investors.pepsico.com
- pepsico.com
- SEC EDGAR: Pfizer Inc. Annual Filings (10-K, 8-K)
- Pfizer Inc. Corporate Website
- Pfizer Inc. Annual Report 2025 - Revenue and Financial Data
- sec.gov
- investors.pfizer.com
- pfizer.com
- investors.pfizer.com